🚨Pleased to advance to #Rheumavision finals !
👏 Congrats to all finalists, to @EMEUNET & @eular_org for this amazing event !
Really excited for the Grand Finale
➡️ So tune in🗓️June 12th at 15:45 ⏰ Hall 6
See you in #EULAR_25 Go #Team_🇫🇷 !!
🎤Get ready for the RheumaVision Grand Finale at #EULAR2025!
🔥Six finalists! Five-minute inspiring talks! And YOU get to vote for the winner! 🏆
📅 June 12, 2025 | 15:45 CEST
📍Hall 6, EULAR Congress, Fira Barcelona
Watch the video here👉https://t.co/4rxPAOr6Od
@EMEUNET
🚨Avacopan Original publication Retracted from @NEJM
« The primary end-point assessments in nine patients were readjudicated after database lock and trial unblinding. This was not disclosed in the article and is inconsistent with proper research conduct»
https://t.co/8dIq5ZyNIz
🎙️ Meet Marta Raschellà (@axadorable), one of our EMEUNET Social Media Correspondents for #EULAR2026!
Marta can't wait to share her congress experience with you all.
▶️ Watch her introduction and follow along for highlights from London!
#EULAR2026#EMEUNET#Rheumatology
Only one day remaining until #Rheumavision finals begin ! 🎤
Until then make sure to stop by the Eular village where you can have your printed picture with #eularEmeunet & #Rheumavision signs 📸
Get ready to experience #EULAR2026 live from London with our dynamic EMEUNET Social Media Correspondents! 🎙️
👩⚕️ Marta Raschellà @axadorable
👩⚕️ Daliya Pencheva @daliya_pencheva
Stay tuned for exclusive session highlights and behind-the-scenes action!
#EULAR2026#EMEUNET
Case: Women in her 20's presenting with chronic walking difficulties and pelvic pain evolving over several weeks.Pelvic X-ray shows abnormalities that warrant careful analysis.
✍️What would be your diagnosis?
#Rheumatology#MedEd@IhabFathiSulima@DrAyubaD@Rheumat_Aravind
A 52-year-old woman had presented with persistent inflammatory edema of the lower limb and a history of squamous cell #carcinoma.
What is your diagnosis? https://t.co/egPTmEGJYo
🧵📊 Treat-to-target in osteoporosis: how achievable are non osteoporotic T-scores?
I was introduced to studies by Cosman et al. during the 39th "Journée du Groupe de Recherche sur l’Ostéoporose (GRIO)" presented as influential papers in 2025
#Osteoporosis#GRIO#TreatToTarget
🎤 Dr Caterina Ricordi showcasing :
⚡️Incomplete B-Cell depletion at final infusion of ANCA RTX maintenance treatment 📈 risk of relapse
⚡️Younger age & ⬆️ initial serum creatinine 📈 risk of incomplete B-cell depletion
#ACR25#EMEUENT@EMEUNET
🚨Pr Xavier Puechal presenting results of the MAINRITSEG trial in #ACR25
⚠️RTX ❌ not superior to AZA in EGPA maintenance
⚡️No difference in 🥇outcome, relapses, GC sparing or AE whatever the ANXA status / severity
⚠️Severe COVID infection RTX > AZA
#EMEUENT@EMEUNET
@Maxime_Samson21 Presenting METOGIA
⚡️TCZ vs MTX in GC sparing in GCA
🥇MTX did not achieve non inferiority (at wk 76 TCZ 51% vs 39% MTX)
⚡️TCZ > MTX for most 🥈outcomes at wk 52
🚨Watch out for Pneucystosis on High GC doses & MTX
#ACR25#EMEUNET@EMEUNET